BAT
NDC 60492-0075, Botulism Antitoxin Heptavalent, liquid, from Emergent BioSolutions Canada Inc.
- Product NDC
- 60492-0075
- Status
- Listed
- Labeler
- Emergent BioSolutions Canada Inc
- Dosage form
- LIQUID
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125462
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60492-0075 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB24500 [iU]/10mL
- EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB23300 [iU]/10mL
- EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB23000 [iU]/10mL
- EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2600 [iU]/10mL
- EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB25100 [iU]/10mL
- EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB23000 [iU]/10mL
- EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2600 [iU]/10mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60492-0075-2 | 60492007502 | 6 VIAL, GLASS in 1 CARTON (60492-0075-2) / 50 mL in 1 VIAL, GLASS (60492-0075-1) |
| 60492-0075-4 | 60492007504 | 1 VIAL, GLASS in 1 CARTON (60492-0075-4) / 50 mL in 1 VIAL, GLASS (60492-0075-1) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 60492-0075 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60492-0075 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60492-0075. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.